Blood Lactate Levels in Patients on Antipsychotics
Author Information
Author(s): Trpimir Glavina, Damir Mrass, Tajana Dodig, Gordana Glavina, Shelly Pranić, Boran Uglešić
Primary Institution: Split Clinical Hospital Center
Hypothesis
A 6-month treatment with haloperidol or olanzapine would change blood lactate levels and cause extrapyramidal side effects in patients without prior antipsychotic treatment.
Conclusion
Haloperidol treatment increases blood lactate levels and the risk of extrapyramidal side effects compared to olanzapine.
Supporting Evidence
- Patients receiving haloperidol had significantly higher blood lactate levels than those receiving olanzapine.
- Haloperidol treatment was associated with a higher incidence of parkinsonism and other extrapyramidal side effects.
- Significant correlations were found between blood lactate levels and extrapyramidal symptoms in patients treated with haloperidol.
Takeaway
This study found that patients taking haloperidol had higher blood lactate levels and more side effects than those taking olanzapine.
Methodology
The study compared blood lactate levels in 60 patients with psychotic disorders treated with either haloperidol or olanzapine over 6 months.
Potential Biases
The non-randomized design may introduce bias in treatment assignment.
Limitations
The study was non-randomized and lacked a true control group, which may affect the validity of the comparisons.
Participant Demographics
Men aged 20-50 years with psychotic disorders.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website